4 Results for "

SPPARM

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SPPARM" in MCE Product Catalog:

Cat. No.: HY-117103
CAS No.: 315224-26-1
Purity:  99.64%
Synonyms: INT131
Target:  

PPAR

Research Areas:  

Metabolic Disease

AMG131 (INT131) is a potent non-thiazolidinedione (TZD) selective peroxisome proliferator-activated receptor γ modulator (SPPARM). AMG131 binds to PPARγ within the same binding pocket as the TZDs, but occupies a unique space in the pocket and contacts the receptor at distinct points from the TZDs. AMG131 is promising for research of type-2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-101292
CAS No.: 193012-35-0
Purity:  99.97%
Target:  

PPAR

Research Areas:  

Metabolic Disease

FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-117103A
CAS No.: 849738-78-9
Synonyms: INT131 benzenesulfonate
Target:  

PPAR

Research Areas:  

Metabolic Disease

AMG131 (INT131) (benzenesulfonate) is a potent non-thiazolidinedione (TZD) selective peroxisome proliferator-activated receptor γ modulator (SPPARM). AMG131 (benzenesulfonate) binds to PPARγ within the same binding pocket as the TZDs, but occupies a unique space in the pocket and contacts the receptor at distinct points from the TZDs. AMG131 (benzenesulfonate) is promising for research of type-2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-101292R
CAS No.: 193012-35-0
Research Areas:  

Metabolic Disease

FK614 (Standard) is the analytical standard of FK614 (HY-101292). This product is intended for research and analytical applications. FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes .
loading...
    loading...